Literature DB >> 30967283

Characteristics and Outcomes of Patients With Cardiogenic Shock Utilizing Hemodialysis for Acute Kidney Injury.

Oluwole Adegbala1, Chakradhari Inampudi2, Adeyinka Adejumo3, Gene Otuonye1, Emmanuel Akintoye2, Razan Elsayed1, Karlene Williams1, Paulino Alvarez2, Luis Afonso4, Alexandros Briasoulis5.   

Abstract

In the setting of cardiogenic shock (CS), impaired biventricular function can cause acute decrease in renal function via reduced renal perfusion and increased renal venous pressure. We sought to analyze the characteristics and outcomes of patients hospitalized with CS who utilized renal replacement therapy (hemodialysis) for acute kidney injury (AKI-HD). We utilized data from the National Inpatient Sample to calculate national rates of in-hospital mortality, use of temporary mechanical support, vascular injury requiring surgery, length of stay (LOS) and hospitalization cost from 2010 to September 2015. We compared the in-hospital outcomes between CS with AKI-HD and a propensity score-matched group without AKI-HD. We identified 6,076 hospitalizations (weighted n = 24,272) with CS and AKI-HD and 76,878 (weighted n = 378,553) with CS not AKI-HD. Among these cases 48.1% (n = 39,403, weighted n = 193,746) had ST elevation myocardial infarction as the cause of CS. Patients with CS and AKI-HD had higher comorbidity burden and they were also more likely to receive mechanical circulatory support device (absolute standardized difference >10% for all comparisons) compared with CS patients without AKI-HD. After matching 4,457 cases for patient-level and hospital-level characteristics, CS with AKI-HD was associated with significantly higher in-hospital mortality (75.74% vs 51.58%, p <0.001), use of temporary mechanical support (24.0% vs 19.3%, p <0.001), LOS (21.4 vs14.4 days, p <0.001) and cost ($80,406 vs $52,833, p <0.0001). AKI-HD occurred in approximately 6% of patients with CS in years 2010 to 2015 and was associated with significantly increased in-hospital morbidity and mortality, LOS, and cost.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 30967283     DOI: 10.1016/j.amjcard.2019.02.038

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Temporal trends, predictors, and outcomes of acute kidney injury and hemodialysis use in acute myocardial infarction-related cardiogenic shock.

Authors:  Saraschandra Vallabhajosyula; Shannon M Dunlay; Gregory W Barsness; Saarwaani Vallabhajosyula; Shashaank Vallabhajosyula; Pranathi R Sundaragiri; Bernard J Gersh; Allan S Jaffe; Kianoush Kashani
Journal:  PLoS One       Date:  2019-09-18       Impact factor: 3.240

2.  Development and External Validation of a Nomogram for Predicting Acute Kidney Injury in Cardiogenic Shock Patients in Intensive Care Unit.

Authors:  Shuai Fu; Quan Wang; Weidong Chen; Hong Liu; Hongbo Li
Journal:  Int J Gen Med       Date:  2022-04-11

3.  National outcomes of urgent vs. non-urgent percutaneous edge-to-edge transcatheter mitral valve repair.

Authors:  Yasser Al-Khadra; Motaz Baibars; Wael Dakkak; Zurain Niaz; Radhika Deshpande; Basma Al-Bast; M Chadi Alraies; Abdul Moiz Hafiz
Journal:  Int J Cardiol Heart Vasc       Date:  2022-07-16

Review 4.  Cardiogenic shock and acute kidney injury: the rule rather than the exception.

Authors:  N Ghionzoli; C Sciaccaluga; G E Mandoli; G Vergaro; F Gentile; F D'Ascenzi; S Mondillo; M Emdin; S Valente; M Cameli
Journal:  Heart Fail Rev       Date:  2020-10-02       Impact factor: 4.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.